This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Paliperidone
INVEGA, INVEGA SUSTENNA, INVEGASUSTENNA, INVEGATRINZA – JANSSEN INC (NOC Search)
Patents:
- 2309629: TEVA
- 2655335: TEVA, PHARMASCIENCE, APOTEX
APOTEX
- PM(NOC) – A-229-23 (2023 FCA 253) – T-1121-22 (2023 FC 912) – T-1122-22 – T-1248-22 – T-1249-22
- Infringement – T-124-21 (2022 FC 107, 2022 FC 1746)
PHARMASCIENCE
- PM(NOC) – T-1441-20 (2022 FC 62, 2022 FC 1218, 2023 FC 1464) – T-455-20 – T-558-22
TEVA
- PM(NOC) – A-131-20 (2023 FCA 68) – T-353-18 (2019 FC 1309, 2020 FC 87, 2020 FC 593, 2022 FC 269)
Return to the Patented Medicine Litigation page.